afrol News, 16 November -
A new malaria treatment [Curemisinin] is being disseminated free-of-charge in clinics located in the Guinean capital Conakry, Bioponic Phytoceuticals announced.
Curemisinin (TM), an all-natural anti-malaria product that is based on three proven effective anti-malaria herbs: Artemesia, Turmeric and Cinchona Bark, is launched by Bioponic Phytoceuticals.
Bioponic is focused on the production of natural products that are used to promote health and well-being and its binary product comprises a nasal spray [Curemisinin A] with an oral spray [Curemisinin B] to treat malaria in the quickest, most effective manner.
The efficacy of Curemisinin will be recorded, and provide valuable data over the next several weeks on the product's ability to treat malaria in humans.
The Chairman and CEO of Bioponic, Steven Schorr said, "Curemisinin's use of a nasal delivery system allows the bioresonant liquid remedy to be delivered directly to the brain via the nasal membrane. This may have a significant impact on cerebral malaria, a condition primarily affecting children, who die within 24 to 7 hours without treatment.
Biponic not only hopes to stop the track of cerebral malaria, but potentially help bring down the cost of treatment and increase the efficacy of treatments for all types of malaria, especially resistant strains of the disease."
Caused by a blood parasite transmitted by mosquitoes, malaria has become the number one killer disease in sub-Saharan Africa. Every year, malaria kills more than a million people worldwide, majority of its victims being African children.
As evolving pathogens develop widespread resistance to over-prescribed antibiotics, anti-virals and antimalarial drugs, the use of natural medicines is being recommended for their proven efficacy in the treatment of vast malaria problem.